Skip to main content
Earnings Labs
4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ·Healthcare·Biotechnology

$9.26

+6.69%

Mkt Cap $461.60M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (16 analysts)

$33.00

Range $33.00$33.00

Implied Upside

+256.4%

Consensus $33.00 vs current $9.26